Navigation Links
Inhaler Linked To Asthma Deaths

Four out of five . Asthma-related deaths per year, in the US were linked to asthma inhalers containing the drugs salmeterol or formoterol //. According to researchers from Cornell and Stanford universities, these drugs should be taken off the market .

They base these conclusions on a statistical analysis of 19 published trials involving 33,826 patients. This so-called meta-analysis found that patients who inhaled the long-acting beta-agonists salmeterol (trade names Serevent and Advair, both made by GlaxoSmithKline) or formoterol (trade name Foradil, made by Novartis Pharmaceuticals) were 3.5 times more likely to die from asthma and 2.5 times more likely to be hospitalized (whether or not death resulted), compared with those taking a placebo.

The reason, say the researchers, is because although these medications relieve asthma symptoms, they also promote bronchial inflammation and sensitivity without warning. Nevertheless, asthma death is relatively rare -- 15 patients in the meta-analysis who were taking the beta-agonists died, compared with three in the placebo group, over a six-month period.

"In total, there are about 5,000 deaths a year due to asthma, whether or not a person is taking a long-acting beta-agonist," said Edwin Salpeter, the J.G. White Distinguished Professor of Physical Sciences Emeritus at Cornell, who led the statistical analysis in the study. An eminent astrophysicist, Salpeter has more recently focused his attention on medical statistics. "We can show that overall it is statistically significant that, compared to patients taking a placebo, these long-acting beta-agonists kill a lot of people," he said.

"These asthma deaths are generally in healthy young adults," said his daughter, Shelley Salpeter, the lead author of the paper appearing online and in the June 20 issue of Annals of Internal Medicine. She is a clinical professor of medicine at Stanford's School of Medicine and a physician at Santa Clara
'"/>




Page: 1 2 3

Related medicine news :

1. Asthma Attacks May Be Triggered By Inhalers
2. FDA Gives Its Approval For Inhaler
3. Inhalers for Kids Was Approved By the FDA
4. Ranbaxy Launches Once-a-day Inhaler For Asthma Patients
5. Breathing Exercises Scores Over Inhalers
6. COPD Patients Using Beta-agonist Inhalers Are at Risk
7. New Inhaler is Childs Play
8. Low Cholesterol Linked to Severe Depression and Violent Behavior in Men
9. Cough Syrup Ingredient Linked to Stroke
10. Irregular Periods Linked to Diabetes
11. Hormones Linked To Migraines
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Inhaler Linked Asthma Deaths

(Date:7/29/2010)... HealthDay Reporter , , THURSDAY, July 29 (HealthDay News) -- ... a better predictor of how well a woman will ... been the traditional way of looking at cancers, new ... the genetic makeup of 595 breast cancer tumors and ... used algorithms to separate the tumors into eight types ...
(Date:7/29/2010)... Administration (FDA) received reports of malignancies in children using ... an associated risk and prompting an investigation. Researchers from ... malignancy in children using infliximab, etanercept, and adalimumab and ... Arthritis & Rheumatism , a journal of the ... approved 3 TNF blockers for use in children: Etanercept ...
(Date:7/29/2010)... , , THURSDAY, July 29 (HealthDay News) -- New research ... the risk of broken bones in postmenopausal women with ... risk seen among men who had been prescribed either ... isn,t the first time such an association has been ... belong to the class of medications known as thiazolidinediones ...
(Date:7/29/2010)... history of male breast cancer perceive themselves to be at ... a family history of female breast cancer; however those with ... know about or seek genetic testing than those with a ... led by researchers at the University of Louisville,s James Graham ... accounts for only about one percent of all breast cancers, ...
(Date:7/29/2010)... new study from Perth,s Telethon Institute for Child Health ... diet in adolescents. , The research findings have just ... Attention Disorders . , Leader of Nutrition studies at ... examined the dietary patterns of 1800 adolescents from the ... ,Western, patterns. , "We found a diet high ...
Breaking Medicine News(10 mins):Health News:Breast Cancer's DNA Yields More Secrets 2Health News:Breast Cancer's DNA Yields More Secrets 3Health News:TNF blockers may increase the risk of malignancy in children 2Health News:TNF blockers may increase the risk of malignancy in children 3Health News:New Data Supports Link Between Diabetes Drugs, Fractures 2Health News:New Data Supports Link Between Diabetes Drugs, Fractures 3Health News:Male breast cancer in family leads to high perception of risk, low likelihood of genetic counseling 2Health News:Male breast cancer in family leads to high perception of risk, low likelihood of genetic counseling 3Health News:Western diet link to ADHD 2
... June 15, 2006 issue of CANCER, a peer-reviewed journal ... radiation// could be a treatment option for men aged ... ,Age has remained a controversial factor, which dictates ... recommend more aggressive therapy as compared to older individuals. ...
... is a generally accepted fact that the doses given ... it is not always clear, how much is enough ... Children’s Center shows that making the dosage a computerized ... well. ,An online infusion calculator and a ...
... leading cardinal has urged Christians to initiate legal action against ... he feels that it offends Christ// and the Church as ... it is enough for us to forgive and to forget,' ... attempts to disclose a murder mystery associated with the life ...
... remembered of the 90 million odd volunteers belonging to the ... back bone of the movement//, and whose helping hand is ... needy all over the world. , ,These unsung heroes ... risking their lives at times, in order to help others ...
... die every day in Madhya Pradesh due to pregnancy related complications, ... ,According to data from the National Family Health Survey (NFHS), the ... which means that out of every 100,000 women, 498 die either ... mother. ,Taking the Census figures, about 1.9 million ...
... apply for a separate insurance scheme as they would no ... may feel that they can go without insurance to save ... or diagnosed with a serious medical problem. Even those ... a few months since there's often a waiting period before ...
Other Medicine News:Health News:Dispensing Drug Dosage To Children Through Computers 2Health News:Dispensing Drug Dosage To Children Through Computers 3Health News:Dispensing Drug Dosage To Children Through Computers 4Health News:Salutations For The Selfless Heroes On World Red Cross Day 2Health News:At Least 25 Women Die Of Maternity Complications In MP Everyday 2Health News:Insurance Plans after Graduation 2
(Date:7/29/2010)... Vermillion, Inc. (Nasdaq: VRML ), a molecular diagnostics company, will host ... issuance of Q2 financial results on Monday, August 16, 2010 . ... Conference Call Information ... To access the ... United States and Canada or +1 212 231 2901 ...
(Date:7/29/2010)... response to the agreement announced that CVS Caremark would provide pharmacy ... the National Community Pharmacists Association (NCPA) issued the following statement from ... H. Harmison , PD: , ... (Logo: http://photos.prnewswire.com/prnh/20100106/DC33253LOGO ) , ... (Logo: http://www.newscom.com/cgi-bin/prnh/20100106/DC33253LOGO ) , ...
(Date:7/29/2010)... , July 29 ... from a Phase Ib/II clinical trial in ... unique, investigational new drug for the treatment ... endpoint demonstrating that ITI-007 was safe and ... addition, several exploratory endpoints were evaluated. Treatment ...
Breaking Medicine Technology:Vermillion to Host Conference Call and Web Cast to Present Company Update and Review Financial Results for the Second Quarter 2010 2Vermillion to Host Conference Call and Web Cast to Present Company Update and Review Financial Results for the Second Quarter 2010 3NCPA Statement on CVS Caremark-Aetna Agreement 2NCPA Statement on CVS Caremark-Aetna Agreement 3Intra-Cellular Therapies Announces the Successful Completion of a Phase Ib/II Study of ITI-007 in Patients with Schizophrenia 2Intra-Cellular Therapies Announces the Successful Completion of a Phase Ib/II Study of ITI-007 in Patients with Schizophrenia 3Intra-Cellular Therapies Announces the Successful Completion of a Phase Ib/II Study of ITI-007 in Patients with Schizophrenia 4Intra-Cellular Therapies Announces the Successful Completion of a Phase Ib/II Study of ITI-007 in Patients with Schizophrenia 5Intra-Cellular Therapies Announces the Successful Completion of a Phase Ib/II Study of ITI-007 in Patients with Schizophrenia 6Nautilus IDScan net Presents New Drivers 26apos 3B License Parsing Component a Magic Tool for Software Developers 71238 1Nautilus IDScan net Presents New Drivers 26apos 3B License Parsing Component a Magic Tool for Software Developers 71238 2Nautilus IDScan net Presents New Drivers 26apos 3B License Parsing Component a Magic Tool for Software Developers 71238 3Nautilus IDScan net Presents New Drivers 26apos 3B License Parsing Component a Magic Tool for Software Developers 71238 4Nautilus IDScan net Presents New Drivers 26apos 3B License Parsing Component a Magic Tool for Software Developers 71238 5MarijuanaDoctors com Announces Weed Team Contest Winner Adds Additional Trip to the Cannabis Cup in Amsterdam 71236 1MarijuanaDoctors com Announces Weed Team Contest Winner Adds Additional Trip to the Cannabis Cup in Amsterdam 71236 2MarijuanaDoctors com Announces Weed Team Contest Winner Adds Additional Trip to the Cannabis Cup in Amsterdam 71236 3New Book Reveals the Powerful and Undermining Impact of Stress on Good Decision Making and What Leaders Can Do About It 71233 1New Book Reveals the Powerful and Undermining Impact of Stress on Good Decision Making and What Leaders Can Do About It 71233 2New Book Reveals the Powerful and Undermining Impact of Stress on Good Decision Making and What Leaders Can Do About It 71233 3
... Oncolytics,Biotech Inc. ("Oncolytics") announces that a poster by ... York, entitled "In Vivo Synergy between,Oncolytic Reovirus and ... be presented today at the American,Association for Cancer ... meeting runs from April 14-18, 2007. , The ...
... WIRE)--Apr 17, 2007 - ZIOPHARM Oncology,Inc. (NASDAQ: ... strongly supportive of the development of an ... high,bioavailability when administered orally; in addition it ... to oral,administration. These data were presented in ...
Other Medicine Technology:Oncolytics Biotech Inc. Research Collaborators Demonstrate,Reovirus/Gemcitabine Combination Has Synergistic Effect Against,Human Colon Cancer Cell Lines 2Oncolytics Biotech Inc. Research Collaborators Demonstrate,Reovirus/Gemcitabine Combination Has Synergistic Effect Against,Human Colon Cancer Cell Lines 3ZIOPHARM Presents Data Highlighting Oral ZIO-101 at AACR 2ZIOPHARM Presents Data Highlighting Oral ZIO-101 at AACR 3
Eschenbach's new 2636 series of stand magnifiers delivers the benefits of high power and a large fields of view. Using a unique doublet lens design, the 2636 offers the highest power recatngular lens...
The Multi-Purpose Stand Magnifier is the most versatile stand magnifier. The stand has multiple configurations allowing for all situations where hands-free magnification is needed....
Bausch & Lomb magnifiers incorporates precision optics and patented ergonomic designs for increased clarity and comfort during use....
Bausch & Lomb round and rectangular magnifiers incorporate precision optics and an ergonomic design for increased clarity and comfort during use...
Medicine Products: